Results 71 to 80 of about 169,398 (330)

The Effect of Rekattidiri Ovitrap Towards Aedes Aegypti Larval Density [PDF]

open access: yes, 2017
Dengue Hemorrhagic Fever (DHF) is a health problem in Indonesia. The entire region of Indonesia at risk of contracting dengue disease. The study aims to prove the effect of modifications ovitrap rekattidiri on the density of larvae (HI: House Index, CI ...
Hadisaputro, S. (Soeharyo)   +3 more
core   +2 more sources

The reemergence of dengue virus in Sudan

open access: yesJournal of Infection and Public Health, 2023
Dengue fever (DF) is a mosquito-transmitted arboviral disease caused by 1 of 4 closely related but antigenically distinct serotypes of dengue virus (DENV), DENV-1-4. The primary vector of DENV is Aedes aegypti and Aedes albopictus mosquitoes. Humans are the main carrier of the virus and the amplifying host with non-human primates plays a considerable ...
Mujahed I. Mustafa   +1 more
openaire   +3 more sources

Carbon Quantum Dots Assisted Virus Tracking: From Skin to Brain

open access: yesAdvanced Materials, EarlyView.
A novel carbon quantum dots‐dissolvable microneedle, CQDs‐dMN system, enables painless delivery and real‐time tracking of HSV‐1. The HSV‐1 is labeled with fluorescent CQDs and delivered to the skin dermis, minimizing damage compared to traditional methods.
Yaxiu Feng   +11 more
wiley   +1 more source

Serological Survey of Dengue Virus Immunoglobulin M Among Febrile Patients in Kaduna Metropolis, Nigeria

open access: yesAceh International Journal of Science and Technology, 2014
The purposes of this research were to determine the prevalence of dengue virus in the study population, to determine the relationship between the occurrence of dengue virus IgM and potential risk factors and to determine the association between the ...
Matthew O. Idoko   +2 more
doaj   +1 more source

Small-molecule endoplasmic reticulum proteostasis regulator acts as a broad-spectrum inhibitor of dengue and Zika virus infections [PDF]

open access: hybrid, 2021
Katherine M. Almasy   +5 more
openalex   +1 more source

Immature Dengue Virus: A Veiled Pathogen?

open access: yesPLoS Pathogens, 2010
Cells infected with dengue virus release a high proportion of immature prM-containing virions. In accordance, substantial levels of prM antibodies are found in sera of infected humans. Furthermore, it has been recently described that the rates of prM antibody responses are significantly higher in patients with secondary infection compared to those with
Rodenhuis-Zybert, I.A.   +6 more
openaire   +7 more sources

The Medicinal Chemistry of Dengue Virus [PDF]

open access: yesJournal of Medicinal Chemistry, 2016
The dengue virus and related flaviviruses are an increasing global health threat. In this perspective, we comment on and review medicinal chemistry efforts aimed at the prevention or treatment of dengue infections. We include target-based approaches aimed at viral or host factors and results from phenotypic screenings in cellular assay systems for ...
Behnam, M.   +3 more
openaire   +3 more sources

Tailoring Advanced Metal‐Based Nanomedicines for Adaptable Nanodynamic Disease Therapies and Theranostics

open access: yesAdvanced Materials, EarlyView.
This review summarizes recent advances in metal‐based nanomaterials (MBNs) as multifunctional platforms for next‐generation diagnostics and nanodynamic therapies (NDTs), highlighting their structural tunability, diverse therapeutic modalities, and broad biomedical applications in oncology and infectious disease control.
Qihang Ding   +11 more
wiley   +1 more source

REVIEW ARTICLE: DEVELOPEMENT AND USING DENGUE VACCINE FOR DENGUE INFECTION VIRUS

open access: yesMedical and Health Science Journal, 2019
: Tropical and subtropical countries are regions with high incidence of dengue infection. Dengue virus infection is estimated to cause 300 million new infections in one year and approximately 1 million severe cases with 2 + 5% deaths.
Firdaus Kabiru Massey, Rika Yulia
doaj   +1 more source

Neutropenia as an adverse event following vaccination : results from randomized clinical trials in healthy adults and systematic review [PDF]

open access: yes, 2016
Background : In the context of early vaccine trials aimed at evaluating the safety profile of novel vaccines, abnormal haematological values, such as neutropenia, are often reported.
Aerssens, Annelies   +10 more
core   +4 more sources

Home - About - Disclaimer - Privacy